ProShares Ultra Nasdaq Biotechnology BIB 80.27 -2.81 (-3.38%) Jun 05, 2026

  • Overview
  • Dividends
  • Performance
  • Calculators
  • Rolling Returns
  • Drawdowns

Overview


Fund Assets 45.49M
Expense Ratio 0.95%
Category Trading–Leveraged Equity
Dividend 0.01
Ex-Dividend Date Mar 25, 2026
Annualized Return (1Y) 79.08%
Annualized Return (3Y) 14.80%
Annualized Return (5Y) -2.15%
Annualized Return (10Y) 5.48%
Annualized Return (15Y) 15.63%
Volume 3,100
Close 80.27
Previous Close 83.08
Worst 3Y Roll AR -17.03%
Worst 5Y Roll AR -10.19%
Worst 10Y Roll AR -6.80%
Worst 15Y Roll AR 14.44%
Inception Date Apr 09, 2010
loading…

Dividends


ProShares Ultra Nasdaq Biotechnology (BIB) Dividend Information

ProShares Ultra Nasdaq Biotechnology (BIB) dividend growth in the last 12 months is -47.72%

The trailing 12-month yield of ProShares Ultra Nasdaq Biotechnology is 1.09%. Its dividend history:

Pay Date Cash Amount
Mar 25, 2026 $0.007
Dec 24, 2025 $0.135
Sep 24, 2025 $0.181
Jun 25, 2025 $0.171
Mar 26, 2025 $0.131
Dec 23, 2024 $0.396
Sep 25, 2024 $0.153
Jun 26, 2024 $0.265
Mar 20, 2024 $0.04
Dec 20, 2023 $0.038

ProShares Ultra Nasdaq Biotechnology (BIB) Dividend Calculator

$
Total Dividend Accrued
$ 1,460.00
Annualized Dividend Yield
10.68 %

Dividend Growth History for ProShares Ultra Nasdaq Biotechnology (BIB)

Year
Payout Amount
Year Start Yield
Annual Payout Growth (YoY)
CAGR to 2025
2025 $0.618 1.20% -27.63% -
2024 $0.854 1.44% 2,147.37% -27.63%
2023 $0.038 0.07% 90.00% 303.28%
2022 $0.02 0.02% - 213.80%
2010 $0.011 0.15% - 30.81%

Dividend Growth Chart for ProShares Ultra Nasdaq Biotechnology (BIB)


Performance


Compare

ProShares Ultra Nasdaq Biotechnology (BIB) Historical Returns And Risk Info

From 04/08/2010 to 06/05/2026, the compound annualized total return (dividend reinvested) of ProShares Ultra Nasdaq Biotechnology (BIB) is 16.034% . Its cumulative total return (dividend reinvested) is 1,000.478% .

From 04/08/2010 to 06/05/2026, the Maximum Drawdown of ProShares Ultra Nasdaq Biotechnology (BIB) is 67.2%.

From 04/08/2010 to 06/05/2026, the Sharpe Ratio of ProShares Ultra Nasdaq Biotechnology (BIB) is 0.31.

From 04/08/2010 to 06/05/2026, the Annualized Standard Deviation of ProShares Ultra Nasdaq Biotechnology (BIB) is 47.9%.

From 04/08/2010 to 06/05/2026, the Beta of ProShares Ultra Nasdaq Biotechnology (BIB) is 1.88.

Name YTD Return 1Yr AR 3Yr AR 5Yr AR 10Yr AR 15Yr AR 20Yr AR Common Inception
BIB (ProShares Ultra Nasdaq Biotechnology) 0.63% 79.08% 14.80% -2.15% 5.48% 15.63% NA ... ...
VFINX (VANGUARD 500 INDEX FUND INVESTOR SHARES) 8.36% 25.68% 21.46% 13.27% 15.16% 14.31% 11.21% ... ...
Data as of 06/05/2026, Common starting date is 04/09/2010

Return Calculator for ProShares Ultra Nasdaq Biotechnology (BIB)

Start date (MM/dd/yyyy)

End date   (MM/dd/yyyy)

ProShares Ultra Nasdaq Biotechnology (BIB) Historical Return Chart


Calculators


Dollar Cost Average Calculator for ProShares Ultra Nasdaq Biotechnology (BIB)

Starting Amount:
Investment Length (years):
Investment Symbol:
Regular Investment Amount ($):
DCA Frequency:
Share on

Retirement Spending Calculator for ProShares Ultra Nasdaq Biotechnology (BIB)

Starting Amount:
Period (Years):
Investment Portfolio or Fund:
Withdrawal Rate (%) :
%
Withdrawal Frequency:
Share on

Rolling Returns


A rolling return for a period such as 5-year, as of a specific date, represents the investment’s performance over the preceding five years leading up to that date. In the 5-year rolling chart, the value on any given date corresponds to the annualized return for the preceding 5 years up to that very date. Thus, for instance, the chart value on 8/28/2015 reflects the annualized return from 8/28/2010 to 8/28/2015. A 5-year rolling return chart for an investment (stock, fund or portfolio) depicts the return sequence of 5-year trailing returns for the dates in the chart.

These rolling returns contrast with the most recent 3, 5, 10, and 15-year returns, as they solely depict the returns for those respective periods leading up to the most recent date, without encompassing every date in the historical record.

Rolling return charts offer a more precise insight into a portfolio’s risk and return stability (including funds or individual stocks). This is particularly true when focusing on the minimal return points within a rolling return chart as a measure of a fund or a portfolio's risk. A well-known observation, often attributed to ‘Murphy’s law’, is that it tends to perform poorly when investors decide to follow an investment due to its recent strong returns. Sound familiar? Information regarding minimum rolling returns could help mitigate this predicament. Investors can opt for an investment showcasing high minimum rolling returns within their preferred holding durations. In fact, merely possessing knowledge of such minimum rolling period returns can anchor investors’ expectations.

For instance, let’s consider an investor who follows a model portfolio (or even simply purchases and holds a fund like VFINX or SPY) for 10 years. Armed with knowledge of this portfolio’s minimum 10-year rolling return since its inception date or the fund’s inception (in the case of VFINX, recognizing that the minimum 10-year rolling return since 1987 could be as low as -2.24%), the investor should reasonably anticipate the potential for the portfolio to incur losses over the forthcoming 10 years.

Minimum rolling return for a period such as 10-year offers a different and often better historical risk and return metric than other popular risk and return metrics such as Sharpe ratio, standard deviation (volatility) or maximum drawdown.

See Portfolio Calculator and Rolling Returns for more detailed description.

From 04/08/2010 to 06/05/2026, the worst annualized return of 3-year rolling returns for ProShares Ultra Nasdaq Biotechnology (BIB) is -17.03%.
From 04/08/2010 to 06/05/2026, the worst annualized return of 5-year rolling returns for ProShares Ultra Nasdaq Biotechnology (BIB) is -10.19%.
From 04/08/2010 to 06/05/2026, the worst annualized return of 10-year rolling returns for ProShares Ultra Nasdaq Biotechnology (BIB) is -6.8%.

Drawdowns


ProShares Ultra Nasdaq Biotechnology (BIB) Maximum Drawdown



Related Articles for ProShares Ultra Nasdaq Biotechnology(BIB)